{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:26:31Z","timestamp":1791084391172,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:p>Epstein\u2010Barr virus lymphoproliferative disease (EBV\u2010LPD) following allogeneic stem cell transplantation (allo\u2010SCT) has a poor prognosis. We used a sensitive real\u2010time polymerase chain reaction (PCR) assay for quantitative detection of EBV\u2010DNA in plasma and serially measured EBV\u2010DNA levels to assess the response to treatment in allo\u2010SCT recipients with EBV\u2010LPD. Fourteen allo\u2010SCT recipients with EBV\u2010LPD who received a T cell\u2010depleted (TCD) sibling (<jats:italic>n<\/jats:italic>\u2003=\u20035) or matched unrelated donor (<jats:italic>n<\/jats:italic>\u2003=\u20039) graft were monitored from the time of EBV\u2010LPD diagnosis, during therapy and assessment of clinical response. Seven patients had complete responses of EBV\u2010LPD to therapy, of whom 21% (3 out of 14) survived beyond 6\u2003months from EBV\u2010LPD diagnosis. Clinically responding patients showed a rapid decline of EBV\u2010DNA plasma levels within 72\u2003h from the start of therapy. In contrast, all clinical non\u2010responders showed an increase of EBV\u2010DNA levels. Absolute EBV\u2010DNA levels at the time of EBV\u2010LPD diagnosis did not predict for response, but the pattern of EBV\u2010DNA levels within 72\u2003h from the start of therapy (&gt;\u200350% decrease versus increase) strongly predicted for clinical response (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7001). Quantitative monitoring of EBV\u2010DNA levels from the start of and during therapy for EBV\u2010LPD rapidly and accurately predicts for response to therapy as early as within 72\u2003h. It may thus provide a powerful tool to adjust and select treatment in individuals with EBV\u2010LPD following allo\u2010SCT.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02789.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:34:18Z","timestamp":1047364458000},"page":"814-821","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein\u2013Barr virus\u2010associated lymphoproliferative disease after allogeneic stem cell transplantation"],"prefix":"10.1111","volume":"113","author":[{"given":"Joost W. J.","family":"Van Esser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert G. M.","family":"Niesters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F. T.","family":"Thijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D. M. E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja C.","family":"Wolthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A. B.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem","family":"Gratama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo M.","family":"Budel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronno","family":"Van Der Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton M.","family":"Van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"L\u00f6wenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo F.","family":"Verdonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199902)45:2<259::AID-ANA19>3.0.CO;2-G"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1128\/JCM.37.10.3430-3431.1999","article-title":"Detection of Epstein\u2010Barr virus DNA in plasma from patients with lymphoproliferative disease after allogeneic bone marrow transplantation or peripheral blood stem cell transplantation (letter)","volume":"37","author":"Beck R.","year":"1999","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.9.1395"},{"key":"e_1_2_6_5_1","first-page":"S66","article-title":"A retrospective Dutch\u00a0study comparing T cell\u2010depleted allogeneic blood stem cell transplantation vs T cell\u2010depleted allogeneic bone marrow transplantation","volume":"21","author":"Cornelissen J.J.","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_6_1","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: a multi\u2010institutional study","volume":"94","author":"Curtis R.E.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)70493-1"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242102"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.2.436"},{"key":"e_1_2_6_10_1","first-page":"437a","article-title":"Semi\u2010quantitative PCR analysis of genomic EBV DNA post\u2010BMT allows\u00a0close surveillance of patients at risk for development of EBV\u2010lymphoproliferative disorders (EBV\u2010LPD) allowing prompt intervention","volume":"92","author":"George D.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199812270-00012"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701554"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V95.3.807.003k24_807_814","article-title":"Epstein\u2010Barr (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV\u2010specific cytotoxic T cells","volume":"95","author":"Gustafsson A.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.4049\/jimmunol.160.12.6204","article-title":"Reconstitution of EBV\u2010specific T cell immunity in solid organ transplant recipients","volume":"160","author":"Haque T.","year":"1998","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0596-551"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.1.132-136.1999"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.2.552.552"},{"key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood.V95.4.1502.004k40_1502_1505","article-title":"CD20 monoclonal antibody (Rituximab) for therapy of Epstein\u2010Barr virus lymphoma after hemopoetic stem\u2010cell transplantation","volume":"95","author":"Kuehnle J.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/JCM.37.4.1113-1116.1999","article-title":"Detection of Epstein\u2010Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders","volume":"37","author":"Limaye A.P.","year":"1999","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_6_20_1","first-page":"133","article-title":"Graft\u2010versus\u2010host disease following transplantation of one log versus two log T\u2010lymphocyte\u2010depleted bone marrow from HLA\u2010identical donors","volume":"1","author":"L\u00f6wenberg B.","year":"1986","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2594.bloodjournal8762594"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.10.3654"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701468"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1093\/annonc\/11.suppl_1.S113","article-title":"Humanized anti\u2010CD20 monoclonal antibody (Rituximab) in post transplant B\u2010lymphoproliferative disorder: a retrospective analysis on 32 patients","volume":"11","author":"Milpied N.","year":"2000","journal-title":"Annals of Oncology"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/JCM.38.2.712-715.2000","article-title":"Development of a real\u2010time quantitative assay for detection of Epstein\u2010Barr virus","volume":"38","author":"Niesters H.G.M.","year":"2000","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404283301703"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91150-2"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08904.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.9.2715.2715"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.8.751"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V93.2.467","article-title":"Comparison of immune reconstitution after unrelated and related T\u2010cell depleted bone marrow transplantation: effect of patient age and donor lymphocyte infusion","volume":"93","author":"Small T.N.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_32_1","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1182\/blood.V83.10.3090.3090","article-title":"Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft","volume":"83","author":"Verdonck L.F.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/jcm.33.7.1765-1768.1995","article-title":"Detection and quantification of virus DNA in plasma of patients with Epstein\u2010Barr virus\u2010associated diseases","volume":"33","author":"Yamamoto M.","year":"1995","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-0934(99)00013-0"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02789.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02789.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02789.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T15:10:32Z","timestamp":1695827432000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02789.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02789.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02789.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"2002-01-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}